Cargando…
Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease
Chronic kidney disease is associated with an increased risk for cardiovascular and bleeding events. Data regarding the effectiveness and risks of aspirin therapy for primary prevention in the high-risk group of patients with chronic kidney disease are scant and controversial. This retrospective stud...
Autores principales: | Haim-Pinhas, Hadar, Yoskovitz, Gil, Lishner, Michael, Pereg, David, Kitay-Cohen, Yona, Topaz, Guy, Sela, Yaron, Wand, Ori, Rozenberg, Ilan, Benchetrit, Sydney, Cohen-Hagai, Keren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588077/ https://www.ncbi.nlm.nih.gov/pubmed/36273098 http://dx.doi.org/10.1038/s41598-022-22474-9 |
Ejemplares similares
-
Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19
por: Gur, Efrat, et al.
Publicado: (2022) -
Mortality prediction using a modified R(2)CHA(2)DS(2)-VASc score among hospitalized COVID-19 patients
por: Levy, David, et al.
Publicado: (2022) -
Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients
por: Nacasch, Naomi, et al.
Publicado: (2022) -
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022) -
Intracranial and heart valve calcifications in hemodialysis patients—Interrelationship and clinical impact
por: Fanadka, Feda, et al.
Publicado: (2022)